Advisory Board

What The Advisory Board Does

Our advisory board brings together business, academic and regulatory leaders to aid The Biofilms Alliance by guiding the strategic direction and development of the alliance. They advise on the development of the network, stakeholder engagement and commercial exploitation of the results of Biofilm Alliance activities.

The Advisory Board

The Biofilm Alliance advisory board currently consists of

Yves

Professor of Pharmaceutical Microbiology at Cardiff University (Wales)

Professor Jean-Yves Maillard

Professor Jean-Yves Maillard has 28 years of experience in the field of biocidal product efficacy and microbial resistance, with a particular focus on novel disinfection technologies, sporicides, complex hydrated biofilms, and dry surface biofilms. Over the years, Professor Maillard has received multiple awards, including those for innovation and engagement. He has published more than 200 peer-reviewed articles, 20 book chapters, and 3 books, as well as over 150 refereed conference communications.He is the European lead for the COMplex Biofilms and AMR Transmission project. He is a committee member of the British Standards Institute CH216 Products and Biofilms Working group, of the TC330 committee on antimicrobial hard surfaces, and he leads the TC330 Working Group 1, which assesses the risk of emerging antimicrobial resistance following exposure to antimicrobial hard surfaces. He is a member of the Clean Hospitals expert panel. He is a member of the editorial board for the Journal of Antimicrobial Chemotherapy. 

Colum Dunne image

 Head (Dean) of the University of Limerick School of Medicine and Foundation

 Professor Colum Dunne

 Professor Colum Dunne is a Fellow of the Royal College of Pathologists (London) and a Member of the Royal Irish Academy Life and Health Sciences Committee (RIA). Colum is Trustee and Council Member of the Healthcare Infection Society (London).Colum began third level education at University College Cork (UCC). He held senior research roles at Ireland's National Food Biotechnology Centre, UCC’s Departments of Microbiology and Medicine following a period of research at Michigan State University, USA.Having been General Manager of a cancer research centre developing  gene-/chemotherapies and innovative medical devices, Colum joined multinational Glanbia Plc as Director of Research and Board member of the Glanbia Nutritionals group of companies. He is an inventor on multiple patents,  and was CEO / Founding Director of SoloPep Ltd, which commercialised infection risk-reduction medical devices.Colum has published >275 peer-reviewed articles regarding intestinal diseases ( Crohn’s disease and ulcerative colitis), microbial colonisation and infection, host response, healthcare associated infections, prevention and ways to mitigate effects.
 
juncal new

Senior Consultant: Biocides and Efficacy at Arrow Regulatory Limited

Dr Juncal Caubilla Barron

Dr Juncal Caubilla Barron earned her PhD in Microbiology from Nottingham Trent University in 2007, subsequently working at the same university in various research positions for two years.In 2009, Juncal joined a major disinfectant manufacturer as the Expert Centre Microbiologist. Over the next seven years, she advanced through positions of increasing responsibility in microbiology, infection prevention, and regulatory affairs. During this time, Juncal developed expertise in microbiology, efficacy testing, diverse cleaning and disinfection product applications, new product development, stakeholder liaison, customer support, marketing claims, and competitor portfolio review. In 2017, she transitioned to regulatory consultancy, starting with TSG Consulting as their Biocides and Efficacy consultant. In 2020, she moved to Arrow Regulatory Limited as a Senior Consultant on Biocides and Efficacy. Her work involved providing general efficacy advice and support on efficacy requirements for various Biocidal Products Regulation (BPR) product types. She gained extensive experience in developing regulatory strategies for biocides, including data gap analysis, intelligent testing strategies, devising product families, and offering tailored regulatory advice. Juncal also possesses experience with the regulatory needs and testing methods for biofilms formed in Product Types (PT) 2, 3, 4, 11, and 12.

 
 
Markus Busch-1

Global Technology Leader LANXESS Material Protection Products, Germany

Dr Markus Busch

Dr Markus Busch has built a 25-year career as a global technology leader in industrial applications, specialising in water and microbial control across Germany, Switzerland, and Spain. At Dow Water Solutions in Germany (1999-2009), Markus served as a seawater desalination application specialist and leader, driving innovation and growth in seawater reverse osmosis and ultrafiltration while leading lab operations and applying Six Sigma methodologies. From 2010 to 2013, Markus led Dow Water Solutions in Spain as Application Leader for EMEA, designing, commissioning, and staffing a water research centre while spearheading membrane innovation and portfolio leadership. In 2014, Markus advanced to Application Leader for Dow’s water microbial control platform in Switzerland, focusing on new technology scouting, development, and portfolio management. Between 2015 and 2019, Markus served as Application Leader for Microbial Control EMEA at Dow in Switzerland, consolidating teams and improving profitability across Energy & Water, Home & Personal Care, and Industrial Preservation applications. From 2020 to 2022, Markus held the role of Application Leader for Industrial Preservation at Dupont & IFF in Germany, leading teams, driving innovation, and managing organizational transitions. Since 2022, as Global Technology Leader at LANXESS Material Protection Products in Germany, Markus has overseen portfolio management, customer applications, and regulatory support for water and energy applications.

 
Michael Davies

Senior Efficacy Specialist at The Health and Safety Executive (HSE)

Michael Davies

Michael joined the Chemicals Regulation Division (CRD) of the Health and Safety Executive in 2016, specifically the Efficacy team specialising in the regulation of biocidal active substances and products under the Biocidal Products Regulation. Michael represented the UK as a member of the European Chemicals Agency (ECHA) Efficacy Working Group prior to EU Exit. Now a Senior Efficacy Specialist with experience across all 22 product types, he currently represents CRD and GB internationally at the OECD Working Party for Biocides where he contributes to global guidance development and collaborates on current biocidal issues. Nationally he represents CRD at the Rodenticide Resistance Action Group (RRAG) which publishes guidance and information on resistance issues. Specific to the Biofilm Alliance, Michael intends to act as a conduit between the regulator and industry/academia. Specifically, he aims to offer a regulatory context to discussions and contribute his firsthand experience in the application of test standards (EN, BSI, ASTM, OECD etc.) to the development of biofilm specific test methodologies.    
 
 

CONTACT US

Get In Touch With The Team